Investor Alert

London Markets Open in:

Edwards Lifesciences Corp.



After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 5:23 p.m.





0.00 0.00%


Volume 137,804

Quotes are delayed by 20 min


Previous close

$ 77.41

$ 76.94


-0.47 -0.61%

Day low

Day high




52 week low

52 week high




Annual Financials for Edwards Lifesciences Corp.

Operating Activities

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Net Income before Extraordinaries 494.9M569.5M583.6M722.2M1.05B
Depreciation, Depletion & Amortization 65.8M71.2M81.9M77.4M114.6M
Depreciation and Depletion 58.7M63.6M74.1M74.9M110M
Amortization of Intangible Assets 7.1M7.6M7.8M2.5M4.6M
Deferred Taxes & Investment Tax Credit (95M)(37.4M)17.8M(27.3M)12.1M
Deferred Taxes (95M)(37.4M)17.8M(27.3M)12.1M
Investment Tax Credit -----
Other Funds 19.6M35M83.2M197.1M210.1M
Funds from Operations 485.3M638.3M766.5M969.4M1.38B
Extraordinaries -----
Changes in Working Capital 64.4M66.1M234.2M(42.6M)(204.3M)
Receivables (38.3M)(56.7M)(3.9M)(28.7M)(88M)
Accounts Payable 29.4M74M85.2M192.5M(63.5M)
Other Assets/Liabilities 6.5M9.3M(1.5M)17.1M9.4M
Net Operating Cash Flow 549.7M704.4M1B926.8M1.18B

Investing Activities

20152016201720182019 5-year trend
Capital Expenditures (106.5M)(217.4M)(175.5M)(241.7M)(278.4M)
Capital Expenditures (Fixed Assets) (102.7M)(176.1M)(168.1M)(238.7M)(254.4M)
Capital Expenditures (Other Assets) (3.8M)(41.3M)(7.4M)(3M)(24M)
Net Assets from Acquisitions (331.6M)-(192.9M)-(135.2M)
Sale of Fixed Assets & Businesses 2.4M2.4M---
Purchase/Sale of Investments 119.6M4.5M(235.7M)323.2M(158.2M)
Purchase of Investments (1.32B)(1.08B)(1.35B)(478.5M)(568.1M)
Sale/Maturity of Investments 1.44B1.09B1.11B801.7M409.9M
Other Uses -(1.2M)(43.9M)(10M)(24M)
Other Sources --800,0005.2M-
Net Investing Cash Flow (316.1M)(211.7M)(647.2M)76.7M(595.8M)

Financing Activities

20152016201720182019 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock (192.9M)(559M)(649.5M)(648.5M)(102.8M)
Repurchase of Common & Preferred Stk. (280.1M)(662.3M)(763.3M)(795.5M)(263.3M)
Sale of Common & Preferred Stock 87.2M103.3M113.8M147M160.5M
Proceeds from Stock Options -----
Other Proceeds from Sale of Stock 87.2M103.3M113.8M147M160.5M
Issuance/Reduction of Debt, Net 1.9M222.1M176.3M(437.3M)(10M)
Change in Current Debt -----
Change in Long-Term Debt 1.9M222.1M176.3M(437.3M)(10M)
Issuance of Long-Term Debt 31.4M253.5M994.7M688M18.9M
Reduction in Long-Term Debt (29.5M)(31.4M)(818.4M)(1.13B)(28.9M)
Other Funds 32.4M68.4M-(15.4M)(2.8M)
Other Uses (8.9M)--(15.4M)(2.8M)
Other Sources 41.3M68.4M---
Net Financing Cash Flow (158.6M)(268.5M)(473.2M)(1.1B)(115.6M)
Exchange Rate Effect (10.4M)(12.5M)7.9M(6.5M)(3M)
Miscellaneous Funds -----
Net Change in Cash 64.6M211.7M(111.8M)(104.2M)465M
Free Cash Flow 447M528.3M832.6M688.1M925M
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
Powered by StockTwits
Link to MarketWatch's Slice.